Literature DB >> 17015152

Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.

Nasia Safdar1, John Marx, Nicholas A Meyer, Dennis G Maki.   

Abstract

BACKGROUND: We report the effectiveness of preemptive enhanced barrier precautions in containing a methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a university hospital burn unit and further controlling endemic nosocomial MRSA infection in the unit during the succeeding 27 months.
METHODS: During a 6-month period, 12 patients in a 7-bed burn unit were found to be colonized (7) or infected (5) by MRSA. An epidemiologic study was undertaken.
RESULTS: Seven of the 10 strains of MRSA from patients that were available for DNA typing were clonally identical. Early in the outbreak, a health care worker was found to be a concordant nasal carrier and was successfully decolonized with nasal mupirocin. However, despite stringent compliance with isolation of MRSA-positive patients (targeted precautions), new cases of MRSA colonization or infection continued to occur. The outbreak was rapidly terminated after implementing preemptive barrier precautions with all patients in the unit: a new, clean gown and gloves for any physical contact with the patient or their environment. Although 25% of all nosocomial S aureus isolates in our hospital are resistant to methicillin, the incidence of endemic MRSA colonization and infection in the burn unit has remained very low since implementing barrier precautions unit wide (baseline rate, 2.2 [95% CI: 1.0-4.2] cases per 1000 patient-days; outbreak rate, 7.2 [95% CI: 4.4-11.0] cases per 1000 patient-days; post-outbreak termination endemic rate, 1.1 (95% CI: 0.4-2.3) cases per 1000 patient-days). The rate ratio comparing the outbreak and the baseline period was 3.20 (95% CI: 1.40-7.95, P = .002); the rate ratio comparing the post-outbreak period with the baseline period was 0.48 (95% CI: 0.14-1.53, P = .10), and it has not been necessary to screen personnel for MRSA carriage to prevent nosocomial MRSA infections in this highly vulnerable population.
CONCLUSION: Preemptive barrier precautions were highly effective in controlling the outbreak and, most notably, have also been highly effective in maintaining a very low incidence of nosocomial MRSA infection endemically in the succeeding 27 months of follow-up. Use of clean gloves, with or without a gown, bears consideration for all high-risk hospitalized patients to prevent cross transmission of all multiresistant nosocomial pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015152     DOI: 10.1016/j.ajic.2006.01.011

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  21 in total

1.  A staff questionnaire study of MRSA infection on ENT and general surgical wards.

Authors:  P S Phillips; A K Golagani; A Malik; F B Payne
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-07       Impact factor: 2.503

Review 2.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.

Authors:  James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-19       Impact factor: 3.254

4.  Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

Authors:  James A McKinnell; Sarah M Bartsch; Bruce Y Lee; Susan S Huang; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

5.  Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.

Authors:  E Ruppé; A Pitsch; F Tubach; V de Lastours; F Chau; B Pasquet; J-C Lucet; A Andremont; B Fantin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

Review 6.  Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission.

Authors:  James A McKinnell; Susan S Huang; Samantha J Eells; Eric Cui; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-12-21       Impact factor: 3.254

7.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Authors:  Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar
Journal:  JAMA       Date:  2013-10-16       Impact factor: 56.272

8.  Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.

Authors:  Arne Simon; Martin Exner; Axel Kramer; Steffen Engelhart
Journal:  GMS Krankenhhyg Interdiszip       Date:  2009-04-09

9.  Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.

Authors:  Elise M Martin; Dana Russell; Zachary Rubin; Romney Humphries; Tristan R Grogan; David Elashoff; Daniel Z Uslan
Journal:  Infect Control Hosp Epidemiol       Date:  2016-07-26       Impact factor: 3.254

Review 10.  Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations.

Authors:  Enno Stürenburg
Journal:  Ger Med Sci       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.